Table 1.
Demographics and relevant medical history, by history of hospitalization for COVID-19.
| Overall (n = 100) |
PNP (n = 50) |
NNP (n = 50) |
p-value | |
|---|---|---|---|---|
| Age, Median (IQR) | 43.5 [35–54.5] | 51 (41–57) | 36 (29–46) | <0.001 |
| Female, n (%) | 63 (63) | 24 (48) | 39 (78) | 0.002 |
| Race, Hispanic/Latino, n (%) | 100 (100) | 50 (100) | 50 (100) | |
| BMI, Median (IQR) | 27 [24–29.7] | 28.9 (26.3–32.5) | 24.7 (22.3–27.0) | <0.001 |
| Years of education, Median (IQR) | 16 [11–16] | 13 (11–16) | 16 (16–18) | <0.001 |
| Months from symptoms onset, Median (IQR) | 27.4 [21–30.4] | 28.2 (24.4–30.4) | 24.8 (17.1–31.9) | 0.052 |
| % recovery, Median (IQR) | 70 [50–80] | 70 (50–80) | 70 (60–80) | 1 |
| Second infection, n (%) | 20 (20) | 4 (8) | 16 (32) | 0.003 |
| SARS-CoV-2 vaccination, n (%) | 92 (92) | 44 (88) | 48 (96) | 0.134 |
| SARS-CoV-2 infection after vaccination, n (%) | 34 (34) | 14 (28) | 20 (40) | 0.231 |
| Hospitalization | ||||
| Hospital stay, Median (IQR) | 23 (10–39) | |||
| Intubation | 20 (40) | |||
| Encephalopathy | 29 (58) | |||
| Neurological comorbidities, n (%) | ||||
| Headache | 28 (28) | 12 (24) | 16 (32) | 0.373 |
| Traumatic brain injury or concussion | 1 (1) | 1 (2) | 0 | |
| Encephalitis | 1 (1) | 1 (2) | 0 | |
| Non neurological comorbidities, n (%) | ||||
| Hypertension | 23 (23) | 16 (31) | 7 (14) | 0.032 |
| Dyslipidemia | 17 (17) | 12 (24) | 5 (10) | 0.062 |
| Diabetes, type II | 9 (9) | 9 (18) | 0 | 0.003 |
| COPD | 4 (4) | 4 (8) | 0 | |
| HIV | 3 (3) | 1 (2) | 2 (4) | |
| Rheumatoid arthritis | 2 (2) | 1 (2) | 1 (2) | |
| Coronary vascular disease | 2 (2) | 2 (4) | 0 | |
| Chronic kidney disease | 2 (2) | 2 (4) | 0 | |
| Smoking | 2 (2) | 2 (4) | 0 | |
| Overall (n = 100) |
PNP (n = 50) |
NNP (n = 50) |
p-value | |
| Alcohol abuse | 2 (2) | 2 (4) | 0 | |
| Hashimoto | 1 (1) | 0 | 1 (2) | |
| Diabetes, type I | 1 (1) | 0 | 1 (2) | |
| Coronary artery disease | 1 (1) | 1 (1) | 0 | |
| Peripheral vascular disease | 1 (1) | 0 (0) | 1 (2) | |
| Congestive heart failure | 1 (1) | 1 (2) | 0 | |
| Cancer | 1 (1) | 1 (2) | 0 | |
| Other drug abuse | 1 (1) | 1 (2) | 0 | |
PNP, post-hospitalization Neuro-PASC; NNP, non-hospitalized Neuro-PASC; COPD, chronic obstructive pulmonary disease. Bold values highlights statistically different (p-value < 0.005).